Abstract
Abstract Limitations in the availability and quality of cancer care have been associated with poor outcomes in medically underserved populations, independent of any biological factors. Differential access and care variation have been documented for many types of cancer and in all phases of care from screening through end-of-life. Patient-level interventions have had a modest impact on cancer disparities that arise in the process of care delivery. Challenges to further understanding and addressing care disparities include reliance on secondary use of data collected for other purposes (e.g., SEER-Medicare) and primary data collection in settings not reflective of the community (e.g., integrated delivery systems). The NCI Community Oncology Research Program (NCORP) integrates a cancer care delivery component offering a new opportunity to study cancer disparities. Cancer care delivery research is defined as the development of “new and generalizable knowledge about the effectiveness, acceptability, cost, optimal delivery mode, active ingredients, and causal mechanisms that influence outcomes and affect the value of cancer care, across diverse settings and populations” (Kent EE et al. J Clin Oncol 2015; 33:2705-11). The ultimate goal is “evidence-based practice change [that will] improve clinical outcomes, enhance patient experiences, and optimize value” (Kent et al.). As is the case for all NCORP efforts, cancer care delivery research considers issues of the medically underserved, particularly racial/ethnic minorities and rural residents, a particular focus. This presentation will describe cancer care delivery research and provide examples of cancer care disparities research that could be conducted within NCORP. Citation Format: Ann M. Geiger. NCORP cancer care delivery research: A new opportunity for studying cancer disparities. [abstract]. In: Proceedings of the Eighth AACR Conference on The Science of Health Disparities in Racial/Ethnic Minorities and the Medically Underserved; Nov 13-16, 2015; Atlanta, GA. Philadelphia (PA): AACR; Cancer Epidemiol Biomarkers Prev 2016;25(3 Suppl):Abstract nr IA27.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
